Final Decision: BUY
Reason: The overall news sentiment around Cipla is positive, with the company announcing strategic partnerships and expansion plans, including an exclusive distribution partnership with Sanofi, which is expected to boost its CNS portfolio in India, and being eligible for same-day settlement, which can increase liquidity and trading volumes.